Latest News

Date Title Topic
09 Oct 2016 ESMO 2016 Press Release: First-line Pembrolizumab Plus Chemotherapy Significantly Improves Outcomes in Advanced NSCLC Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Pembrolizumab New Option for First Line Treatment of Patients with Advanced Lung Cancer and High PD-L1 Expression Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Greater Patient Selection May be Needed for First Line Nivolumab to Improve Progression-free Survival in Advanced Lung Cancer Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Significant Survival Gains with Atezolizumab vs Docetaxel for Non-Small-Cell Lung Cancer Head and neck cancers
09 Oct 2016 ESMO 2016 Press Release: Ceritinib Provides Longer Progression-free Survival Than Chemotherapy in Phase III Trial of ALK Rearranged Lung Cancer Treatment Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Nintedanib Improves Progression-free Survival but not Overall Survival in Phase III Trial of Metastatic Colorectal Cancer Gastrointestinal cancers
08 Oct 2016 ESMO 2016 Press Release: 70% of Advanced Cancer Patients Receive Palliative Care Consultation at ESMO Designated Centres Palliative and supportive care
08 Oct 2016 ESMO 2016 Press Release: Phase I Study of Novel Anti-Cancer Drug Uses Tumour mRNA Expression to Identify Responders Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016 Press Release: Niraparib Significantly Improves Outcome of Ovarian Cancer Patients in Landmark Trial Gynaecologic malignancies
08 Oct 2016 ESMO 2016 Press Release: Ribociclib Improves Progression-free Survival in Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016 Press Release: Ipilimumab as Adjuvant Therapy Improves Overall Survival in High Risk Stage III Melanoma Melanoma and other skin tumours
08 Oct 2016 ESMO 2016 Press Release: Immunotherapy Shows Promising Results in First and Second Line Treatment of Metastatic Bladder Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016 Press Release: Targeting Estrogen Receptor Improves Progression-free Survival in Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
07 Oct 2016 ESMO 2016 Press Release: Thousands of Melanoma Patients in Europe Have no Access to New Life Saving Drugs Melanoma and other skin tumours
07 Oct 2016 ESMO 2016 Press Release: High response rate in phase I/II paediatric brain cancer trial sets stage for combination therapy with higher response and lower toxicity Central nervous system malignancies